title: Intravitreal triamcinolone and elevated intraocular pressure.
abstract: OBJECTIVE
  To ascertain whether intravitreal triamcinolone given for subretinal neovascularization is associated with an ocular pressure rise.
  
  
  METHODS
  A total of 113 patients with angiographically proven subretinal neovascularization were enrolled into a prospective study of the effects of intravitrea triamcinolone. Intraocular pressure was one of the parameters studied.
  
  
  RESULTS
  Approximately 30% of the study group developed a significant rise (> or =5 mm Hg) in intraocular pressure above baseline during the first 3 months.
  
  
  CONCLUSIONS
  Patients considering this form of treatment should be fully informed of the known risks of intraocular injections of steroids.
authors.affiliation: rwingate@internet-australia.com
authors.forename: R J
authors.initials: RJ
authors.lastname: Wingate
authors.forename: P E
authors.initials: PE
authors.lastname: Beaumont
mesh_terms: D005451:Fluorescein Angiography; D005654:Fundus Oculi; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure / Q000187:drug effects*; D008268:Macular Degeneration / Q000150:complications; D009798:Ocular Hypertension / Q000139:chemically induced*; D011446:Prospective Studies; D015861:Retinal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D012307:Risk Factors; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000009:adverse effects* / Q000627:therapeutic use; D014822:Vitreous Body
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide